Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Generic drug APIs and intermediates	2.22B	1.99B	2.00B	2.35B	1.96B
Generic drug APIs and intermediates Growth	11.42%	-0.53%	-14.69%	19.66%	-21.20%
CDMO APIs and Intermediates	391.90M	365.80M	405.66M	263.08M	557.24M
CDMO APIs and Intermediates Growth	7.13%	-9.83%	54.20%	-52.79%	552.65%
Preparations	418.00M	254.76M	105.03M	33.97M	3.97M
Preparations Growth	64.07%	142.56%	209.20%	754.85%	-
other	29.36M	16.13M	11.84M	19.62M	19.88M
other Growth	81.97%	36.26%	-39.66%	-1.29%	103.22%
Total	3.06B	2.63B	2.53B	2.67B	2.55B
Total Growth	16.36%	4.10%	-5.23%	4.78%	-1.64%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Overseas	1.63B	1.72B	1.82B	1.86B	1.85B
Overseas Growth	-5.19%	-5.55%	-2.45%	0.71%	-1.35%
China	1.43B	914.11M	709.76M	803.49M	695.04M
China Growth	56.82%	28.79%	-11.66%	15.60%	-2.40%
Total	3.06B	2.63B	2.53B	2.67B	2.55B
Total Growth	16.36%	4.10%	-5.23%	4.78%	-1.64%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error